BioMérieux acquires Astute Medical for $90 million

BioMérieux acquired Astute Medical, developer of the NephroCheck test, for approximately $90 million.

“BioMérieux has acquired Astute Medical, developer of the NephroCheck test, for approximately $90 million.”captodayonline.com

• 1 source
• captodayonline.comBioMérieux buys Astute Medical - CAP TODAYCAP TODAYApr 24, 2018

Summarized from public sources; check the original articles before acting on it.